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Abstract: The advent of porous materials, in particular zeolitic nanoparticles, has opened up
unprecedented putative research avenues in nanomedicine. Zeolites with intracrystal mesopores are low framework density aluminosilicates possessing a regular porous structure along
with intricate channels. Their unique physiochemical as well as physiological parameters
necessitate a comprehensive overview on their classiﬁcations, fabrication platforms, cellular/
macromolecular interactions, and eventually their prospective biomedical applications
through illustrating the challenges and opportunities in different integrative medical and
pharmaceutical ﬁelds. More particularly, an update on recent advances in zeolite-accommodated drug delivery and the prevalent challenges regarding these molecular sieves is to be
presented. In conclusion, strategies to accelerate the translation of these porous materials
from bench to bedside along with common overlooked physiological and pharmacological
factors of zeolite nanoparticles are discussed and debated. Furthermore, for zeolite nanoparticles, it is a matter of crucial importance, in terms of biosafety and nanotoxicology, to
appreciate the zeolite-bio interface once the zeolite nanoparticles are exposed to the biomacromolecules in biological media. We speciﬁcally shed light on interactions of zeolite
nanoparticles with ﬁbrinogen and amyloid beta which had been comprehensively investigated in our recent reports. Given the signiﬁcance of zeolite nanoparticles’ interactions with
serum or interstitial proteins conferring them new biological identity, the preliminary
approaches for deeper understanding of administration, distribution, metabolism and excretion of zeolite nanoparticles are elucidated.
Keywords: zeolite, mesoporous, nanostructure, biosafety, biomedical applications

Introduction
Porous materials are promisingly sustainable solutions for some global concerns
including rising energy demands along with the need for stricter environmental
approvals for industrial contaminants, depleting resources, and improving health.
The capacity of these porous materials, physically and chemically, is an attraction point due to demonstrating differential local atomic environment once
exposed to solid versus bulk surfaces. Thus, a greater number of surface
atoms, or in better words, an increased speciﬁc surface area of porous solids
will lead to higher material reactivity and improved efﬁcacy in relevant applications. Three strategies have been utilized for this purpose in order to aid size
reduction of dense solids, to generate the bulk of the particles with an open pore
structure, or to combine these two approaches by preparing nanoscale particles
comprising accessible and homogeneous nanopores maximizing the fraction of
atoms exposed to the surface.
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According to the International Union of Pure and Applied
Chemistry (IUPAC), the porous structures are sorted into
three groups based on their pore diameter: microporous
structures with pore diameters up to 2 nm, mesoporous
materials containing pores in the range of 2 −50 nm, and
macroporous solids with pores larger than 50 nm.1
Depending on their structural and compositional characteristics, each of the microporous and mesoporous classes is
further divided into subfamilies of porous materials.
The size of particle itself may be another factor for
classiﬁcation. In general, particles with a size of up to 100
nm, in at least one dimension, are considered nanosized
porous solids that may contain only the microporous and
mesoporous pore ranges.2 Recently developed crystals
with a size that does not exceed 15 nm are known as
ultra-small NPs. Porous solids with uniform, periodic
pore structures are referred to as ordered porous materials.
Porous particles with periodic structures have increasingly
gained attention because they can constitute putative tools
in sensing, separation, storage, and transformation of small
molecules.3 In particular, zeolites are broadly employed in
different areas of industry pertaining to catalysis, adsorption, ion-exchange, etc.4 Due to the large collected number
of publications on synthesis and application of zeolite NPs
and their expanding outreach in biology and medicine, the
goal of this review is to give a summary of recent biomedical applications of the different groups of zeolite porous
nanomaterials.
Zeolites are a class of minerals with an ordered porous
structure having a microporous pore range primarily found
in nature. From the viewpoint of chemical composition,
zeolites are composed of crystalline metal oxides whose
building blocks consist of a tetrahedral atom (eg, Si, P, Al,
Ti, B, Ga, Ge, Fe, etc.) bound to four or two oxygen
atoms, where each oxygen connects to two tetrahedral
atoms.4 The general chemical formula of these porous
structures can be represented by the following formula:
h
i
Mx=n ðAlO2 Þx ðSiO2 Þy wH2 O:M
where “M” represents an alkali/alkaline earth cation with
valence of n, “w” is the number of water molecules, and
“x” and “y” are the molar concentrations of tetrahedra in
the zeolite structure, of which the y/x ratio usually has a
value of 1 to 5. However, this ratio can be increased to 100
in the siliceous zeolites.
Zeolite NPs possess conspicuous advantages in comparison with other nanostructured porous materials including:
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(1) low cytotoxicity which can limit the undesirable effects
on normal cells/tissues, (2) adjustable, high payload capacity which is favorable for increasing the loading content of
zeolite pores, and (3) improved intracellular targeting speciﬁcity and efﬁcacy which beneﬁts drug delivery
applications.
The main advantages of applying NPs as compared to
traditional therapeutics include at least three items: (1)
decreased adverse effects of delivered drugs, (2) higher
level of formulation versatility (eg, conjugation to drugs,
antibodies, peptides, DNA, carbohydrates, etc.), and (3)
destruction of inﬂammatory or tumoral cells thanks to their
electrical, magnetic, or optical characteristics (eg, by the
means of magnetic or optical hyperthermia) used to motivate an effective response.
The three-dimensional structure of natural zeolites, ie,
those with aluminosilicate composition, encompasses
pores and cavities that are captured by water molecules
and alkali or alkali-earth metals. Despite the abundance of
zeolites, their industrial application is limited due to the
presence of impurities and chemical composition diversity
in some natural zeolites. Accordingly, there have been
comprehensive attempts to improve the characteristics of
existing zeolite materials which have led to preparing
novel types of zeolitic frameworks with compositions
extended far beyond the restrictions enforced by the nature. Synthetic zeolite-type solids demonstrate a high
degree of diversity in the Si/Al ratios as compared to
natural minerals and contain other framework elements
including but not limited to Zn, Ga, Ge, P, B, and Be.
The non-classical (non-aluminosilicate) zeolitic frameworks are comprised of all-silica, galo-, alumino-, and
transition metal phosphates along with gallium, zinc, and
germanium silicates.5–8 These new structures/compositions, organic structure-directing agent(s) (SDA) are generally utilized to direct synthesis of new alumino-silicate
zeolites by increasing the Si/Al ratio for preparing high- or
pure-silica zeolites and to promote the synthesis of novel
zeolitic framework forms from synthetic gels comprising
framework atoms other than Si and Al.8–10 New framework types are regularly approved by the Crystallographic
Commission of the International Zeolite Association, and
as of January 2018, there are 235-approved zeolite framework forms.11
The approach in the research and design of zeolite
solids in comparison with other classes of porous materials, such as metal-organic frameworks, has become even
more application-driven.4 Based on a citation network

International Journal of Nanomedicine 2020:15

International Journal of Nanomedicine downloaded from https://www.dovepress.com/ by 134.48.159.153 on 04-Jan-2022
For personal use only.

Dovepress

analysis, low impact factor journals commonly publish
articles related to evaluation of the acidic/basic properties
and reaction mechanism of zeolites; whereas, research on
biomass generation, nanosheet synthesis, and photo/electrocatalysts have been published by high impact factor
journals.4 And this is understandable from the viewpoint
of applications. Principally, zeolites are valuable materials
for catalysis, and more sophisticated investigation ﬁelds
are reviewed in literature.
It must be taken into consideration that the structureproperty relation is important to be realized in the present
situation. The widespread application of zeolites stems
from their solid acid and ion-exchange efﬁciencies owing
to their robust frameworks rooted in their inorganic-based
structures. The diameter of micropores in zeolites is typically less than 0.7 nm, which is applicable for molecular
sieving. Furthermore, incorporation of isolated metal
atoms into the silicate frameworks and/or introduction of
cations via ion-exchange display deﬁning characteristics.
Production of designable zeolites regarding the structural
and physical characteristics will be a challengeable issue
in the future.4
Herein, the present paper encompasses the following
sections:
The ﬁrst section brieﬂy introduces biomaterials, biomedicine, and natural and synthetic mesoporous zeolitic
structures along with their subclasses. The second section
highlights and discusses the relevant approaches for fabrication of these porous materials. The third section presents
some important biomedical applications of these promising nanoplatforms. And the fourth section covers the most
recent advances of zeolite structures and the challenges
encountered in the ﬁeld of biomedicine.

High Throughput Methods for
Fabrication of Zeolitic Porous
Biomaterials with a Focus on
Hydrogel-Based Systems
As noted in the introduction section, zeolitic materials are
synthesized by various methods in ﬁve synthesis systems,
ie, the conventional hydrogel system, the conﬁned-space
synthesis templates, microreactors, top-down approaches,
and zeolite nanosheet synthesis systems.2 Scaling up the
production of zeolites, however, depends on hydrogelbased systems comprising bulk solid and liquid phases,
where the zeolite backbone is formed around charged
templating species, ie, alkali-metal and cation-water
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complexes or organic molecules.12 The production of zeolites through hydrogel systems is based on a strategy,
where the amorphous materials undergo chemical and
structural reorganization until achieving a zeolite
arrangement.13–16 Zeolite nuclei form in the solid portion
of the system, while the zeolite framework propagates to
the gel network until the crystallites are released from the
solid matrix and proceed developing within the mother
liquor. Thus, zeolite production through a hydrogel system
can be considered to take place in three steps: (1) nucleation at gel-liquid interface, (2) growth and release of
zeolite nuclei from gel matrix, and (3) growth within the
mother liquor until completion to the ultimate, fully crystalline zeolite product.
Mass zeolite production in hydrogel compositions
exhibits a considerable degree of heterogeneity. The heterogeneous virtue of zeolite nucleation process has been
consensually approved, and there is typically an agreement
that the nucleation of zeolite deviates from the classical
crystallization process featuring crystal production from
supersaturated solutions.17,18 This is probably one of the
most intricate products of hydrothermal crystallization,
where usually one-unit cell is formed from several hundred atoms. So, the control of zeolite expansion in such
systems is more complicated. The high intricacy and heterogeneity of events in the solid and liquid phases of the
system also create a critical, challengeable issue in monitoring the mechanism of zeolite production. However, a
considerable advancement has been obtained in recent
years, and there is a broad agreement over the fundamental
events occurred during a zeolite nucleation process.19,20
For example, it has become obvious that the size of the
precursor gel particles in the system is determined by
alkaline hydroxide, eg, in case of producing FAU-type
zeolites with industrial applications.
The diameter of the ﬁnal zeolite materials can be regulated by careful and systematic control of the starting gel
chemistry which facilitates formation of ultrasmall-, nanometer-, or micrometer-sized zeolite solids with uniform
particle size distribution. Closed systems are used in order
to synthesize zeolite crystals, where the components of the
initial gel react together, so that this reaction ultimately leads
to nucleation and further growth of the kinetically most
favorable phase. Under these circumstances, controlling the
zeolite growth permits regulating the ﬁnal-crystal size.
Simply put, there is a restriction in the nutrient resources,
and the growth of the solid terminates after the exhaustion of
building components. There is a reverse relationship between
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nucleation process and crystal size, so that increasing the
number of nuclei causes a decrease in the ultimate crystallite
size.21 Therefore, accurate control of the zeolite nucleation
events and simultaneous growth of crystals is needed for
regulation of the zeolite particle scale. The latter is especially
critical when the purpose is production of nanosized particles
with narrow size distribution, in which case the product
homogeneity arises from the temporal and spatial uniformity
of the nucleation process.
Different research teams have focused on FAU-type zeolite materials because of the enormous inﬂuence of these
zeolite types on the petrochemical industry. In the 1990s,
FAU-type nanocrystals were produced, by utilizing huge
quantities of tetramethylammonium hydroxide and 15crown-5 ether, and considerably reduced Na2O amount in
the initial system.22,23 This was followed by several attempts
to increase the production yield.24,25 Valtchev and Bozhilov
illustrated the possibility of synthesizing FAU-type nanomaterials through an organic-template-free system.18 Hu et al
produced submicrometer-sized zeolite Y (a subfamily of
FAU-type) using organic-template-free hydrogels,26 and the
procedure was optimized by Kim et al.27 In 2012, the production of template-free nanosized EMT-type zeolites was
reported by Ng et al. After, in 2015, the fabrication of FAUtype zeolites was reported by Awala et al. These zeolite
materials possessed extraordinary properties, such as highefﬁciency crystalline (above 80%), micropore volumes
(0.30 cm3 g−1) comparable to their conventional counterparts
(micrometer-sized crystals), very small particles (10–15 nm)
with narrow size distribution, extraordinary thermal stability,
and Si/Al ratios that were modiﬁable between 1.1 and 2.1
values (zeolites X or Y) (Figure 1).28,29
Ultrasmall EMT-type material, another solid with a signiﬁcant capacity in catalytic and separation reactions, was
obtained through an organic-template-free system.29 This
nanomaterial was stabilized at nearly ambient temperature
conditions under which ultrasmall nanocrystals (7–15 nm)
were assembled and then were enlarged to 50–70 nm underprolonged crystallization. In addition to the very tiny size,
the uniform particle size distribution in a sodium-rich environment and low production cost are great achievements that
make this synthesis technique unique.
Besides FAU and EMT, zeolite types of BEA, LTI,
MFI, and MOR are some of the other industrially most
important framework types.2 In biological and medical
ﬁelds, the use of zeolites dates back to the early 1990s,
when the capability of FAU (X, Y), LTA (Linde Type A,
zeolite A), and MOR frameworks to be applied as
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magnetic resonance imaging (MRI) contrast agents and/
or bactericidal agents30,31 along with their potential for
dental or pharmacological applications32,33 were realized.
Since then, advances in synthesis of different zeolitic
frameworks have progressively paved the way for expanding their exploitation in biomedical research and industry
sectors. The most applied zeolite types in this area are
FAU, EMT, clinoptilolite, BEA, FER, LTA, LTL (Linde
Type L, zeolite L), MFI, MOR, and ZSM, whose applications are reviewed in the following sections of this review.

Biosafety and Cytotoxicity
The earliest time when the natural zeolite NPs were administered to the human bodies dates back to the late 1920s,
when a series of unprecedented translational and clinical
experiments authenticated by the Cuban Quality Control
Agency were accomplished. This huge and long-lasting
research, which include the basic in vitro experiments
followed by the translational and clinical trials including
acute diarrheic participants whose gastrointestinal (GI)
track is infected by food intoxication, was set out to
investigate the safety and pharmacological efﬁcacy of the
Entrex natural zeolite for diarrheic conditions and their
proposed mechanism of action. Further insights on the
underlying mechanism of action for these natural zeolites
are given in the 4.3. section which overviews zeolites
applicability in anti-diarrhea drugs.
Regarding the diverse fabrication methods of zeolitic
NPs’ platforms in the realm of biomaterial engineering, as
well as the number of scientiﬁc publications built upon
biocompatibility of zeolite NPs, it is worthwhile to
appreciate the cytotoxicity and biocompatibility assessment methods that constitute crucial steps prior to any
clinical interventions. Despite the recent advances made
in fabrication methods, functionalization, and biomedical
applications of zeolitic NPs, the exact mechanism of their
toxicity is still vague. Regarding their beneﬁts in various
biomedical applications, it seems necessary to assess the
cellular toxicity of these molecular sieves. In comparison
with other mesoporous NPs, there are a poor number of
studies reporting physiological toxicity of zeolitic NPs.
Speciﬁcally, it seems that the biosafety of these porous
materials is inﬂuenced by some of the structural features
including but not limited to external surface area, pore
size, surface charge, functional groups, and crystallinity.
In the recent literature, some researchers have raised concerns regarding the cytotoxicity effects of zeolitic NPs on
a multitude of yet understudied cell lines. To this end, a
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Figure 1 TEM images of FAU-type Y-10 (9 nm) (A) and Y-70 (38 nm) (B) nanosized zeolites. The corresponding high-magniﬁcation image of a single nanocrystal is shown as
insets. Ultrasmall EMT-type zeolite was synthesized by Mintova group from template-free precursor suspension at 30°C for 36 hrs (C)28,29. (A) Reprinted by permission
from Springer Nature Customer Service Centre GmbH: Springer Nature; Nature Materials; Template-free nanosized faujasite-type zeolites. Awala H, Gilson J-P, Retoux R, et
al. 2015;14(4):447–451. Copyright 2015.28 (B)From Ng E-P, Chateigner D, Bein T, et al. Capturing ultrasmall EMT zeolite from template-free systems. Science. 2012;335
(6064):70–73. Reprinted with permission from AAAS. Copyright 2012 The American Association for the Advancement of Science.29

series of 150-diverse nanozeolites with different shapes,
sizes, dosages, and surface compositions were synthesized,
and through an in vitro investigation, their dose/timedependent/independent cytotoxicity against human cervix
carcinoma (HeLa) cells were quantitatively and qualitatively evaluated via exploring the cellular death by either a
necrosis or apoptosis pathway. The main conclusion of
their experiments underlined the nontoxicity of the “pure
silica nanozeolite silicalite-1” with spherical morphology,
while the toxicity of other alumina containing nanozeolites
was non-linearly associated with the alumina content. In
addition, it was gathered that nanozeolites with a cubic
morphology were more toxic for HeLa cells as compared
to those with a spherical morphology.34
The important parameters for determining the toxicity
of nanosized zeolites have been disclosed as particle scale
and crystalline structure. A conclusive priority for cellular
necrosis was exhibited over a programmed cell death via
apoptotic processes for the materials with various scales
and morphologies.35
In a study reported in 2011, contrary to the purely siliceous
zeolite, the nanosized zeolites comprising aluminum and silicalite groups demonstrated a noticeable dose-dependent toxicity. Variations in morphology was also determined to have a
profound inﬂuence on zeolites toxicity. Additionally, it was
proposed that the differences in surface charge of the zeolites

International Journal of Nanomedicine 2020:15

could slightly impact their toxicity. Kihara et al evaluated the
cytotoxicities of nanoscaled zeolites including MFI (both
ZSM-5 and silicalite-1), LTA and LTL types against the cell
lines of HeLa, human embryonic kidney 293 (HEK-293), and
RAW264.7 macrophages. Results demonstrated that the toxicities of zeolite nanomaterials depended on their Si/Al ratio,
size (30–500 nm), and morphology. Pure-silica zeolite with
MFI-type structure (silicalite-1) showed no toxicity; however,
the other three nanoscale zeolites comprising aluminum group
exhibited a dose-dependent toxicity (Figure 2).34
In a study done in 2013, HeLa cells were employed to
assess the possible toxicity of zeolite materials against tumor
cells in vitro. It was revealed that coatings of different charges
led to different outcomes regarding serum protein adsorption,
toxicity, agglomeration in media, and cell internalization.
Moreover, it was shown that the disc-shaped zeolite L crystals
could penetrate the tumor cells through multiple pathways.36
It has been reported that functionalization of zeolites could
demonstrate different cytotoxicity levels depending on the
presence of aluminum, and amine modiﬁcation of zeolites
could signiﬁcantly increase their cytotoxicity.5 Regarding the
serious impacts of free radicals on human body, the antioxidant and pro-oxidant properties of well-dispersed nanozeolites were measured. TS-1 zeolite (Ti-containing MFI-type
zeolite) displayed a signiﬁcantly comparable or even more
antioxidant capacity in comparison with cerium oxide. Also,
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Figure 2 Confocal microscopy photos of HeLa cells treated with nanozeolite LTL. HeLa cells (A) and HeLa cells treated with 10 μg.mL−1 of green ﬂuorescent protein (GFP)
adsorbed nanozeolite LTL-90 (B, C). GFP adsorbed nanozeolite attached to the surface of cultured cells (B, arrows) and thimbleful adhered nanozeolites were internalized
into the cells (C, arrowheads). Green color shows GFP adsorbed nanozeolite, and red color exhibits actin ﬁlaments of cells. The cell nucleus part (N) has been lined via a
circle (C). Scale bar is 50 μm.Reprinted from Kihara T, Zhang Y, Hu Y, et al. Effect of composition, morphology and size of nanozeolite on its in vitro cytotoxicity. J Biosci
Bioeng. 2011;111(6):725–730. Copyright 2011, with permission from Elsevier.34

it was concluded that the cytotoxicity of zeolites depended on
type of the cell line utilized in the research emphasizing that in
vitro investigations must employ representative methodologies to achieve reliable data.37
In our previous research, we investigated the toxicity
of both LTL and EMT types of zeolites, categorized in the
common class of molecular sieves, against HeLa cells. The
HeLa cell interaction with both types of zeolite NPs was
assessed by cell viability, reactive oxygen species (ROS),
and cell cycle assays. It was perceived that various doses
of nanozeolites possessed trivial inﬂuence on the cell
cycle. Furthermore, no detectable oxidative stress was
induced in the presence of zeolite nanocrystals in the
cells. Despite the signiﬁcant cellular uptake of zeolites,
none of the employed ultra-small EMT and LTL zeolites,
at any concentrations, induced cytotoxicity (Figure 3).38
By the intervention of synthesis methods, the concern
around cytotoxicity has shifted towards nanoscale materials. Microscale zeolites have been demonstrated to be safe
and non-toxic; whereas, zeolite NPs have not yet been
completely scrutinized regarding their cytotoxicity.39

Biomedical Application of Zeolitic
Materials
Given the unique structure and favorable physiochemical
advantages over other mesoporous nanomaterials, such as
lower cytotoxicity, higher payload capacity, and improved
intracellular targeting speciﬁcity and efﬁcacy, zeolite NPs
are recognized for their improved biocompatibility as well
as adjusted biomolecular delivery capacity.
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Zeolites encompass a broad range of biomedical applications, eg, utilization as antidiarrheal agents, antitumor
adjuvants, antibacterial agents, MRI contrast agents, their
employment in studies on bone formation, Alzheimer’s
disease development, and their hemodialytic, drug delivery, and dental applications (Scheme 1).

Zeolite and Bone Formation
Osteoblast proliferation and differentiation are considered as
signiﬁcant factors that must be taken into account during the
bone regeneration investigations in implants.40 In order to
replacing conventional materials, zeolite crystals can be utilized as implants because their 3D microstructures form a
great network of sub-nanometer pores, and their special
topography turns them into an appropriate substance for
bone cell attachment, proliferation, and expansion.40–42 For
instance, the application of a new composite containing
zeolite–hydroxyapatite, coated on stainless steel and titanium
alloys in regenerative medicine, has been proposed.43 The
zeolite–hydroxyapatite composite is super-hydrophilic, and
the zeolite coating removes the elastic modulus mismatch
between the coating and the bone. Therefore, it may beneﬁt a
quicker post-surgery recovery. Because of the ability of
zeolite A to stimulate bone formation, it possesses therapeutic advantages for individuals experiencing osteoporosis.33 A
signiﬁcant enhancement in the proliferation, differentiation,
and generation of transforming growth factor h (TGF h) has
been detected by applying the zeolite A to the normal, adult
human osteoblast-like cells in vitro. In addition, the DNA
synthesis in these cells has raised dependently to the applied
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Figure 3 (A) HeLa cell viabilities before and after incubation with diverse concentrations of zeolites. (B) HeLa cell viabilities before and after incubation with diverse
concentrations of surface saturated zeolites. (C) ROS generation for zeolites at different concentrations (ie 50–400 μg.mL−1) on HeLa cells after 6 hrs’ incubation; confocal
photos (scale bars are 50 μm) indicate the induced lysosomes (the nucleus and lysosomes are shown as blue and red ﬂuorescence, respectively) and induced ROS level (the nucleus
and ROS level are shown as blue and green ﬂuorescence, respectively) gained by the incubation of HeLa cells with zeolites (concentration of 100 μg.mL Republished with permission
of Royal Society of Chemistry, from Laurent S, Ng E-P, Thirifays C, et al. Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template
free precursor suspensions. Toxicol Res (Camb). 2013;2(4):270–279. Copyright 2013; permission conveyed through Copyright Clearance Center, Inc.38
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dose of zeolite A. Moreover, zeolite A has been able to
increase the release of osteocalcin and the activity of alkaline
phosphatase enzyme. Also, the steady-state mRNA levels of
TGF h1 have increased through the treatment with zeolite
A.44 The suppressive impact of zeolite A on bone-resorption
activity has been discovered in the highly puriﬁed avian
osteoclasts by Schütze et al.45 However, zeolite MFI coatings
on titanium alloys seem to promote attachment of osteoblasts
and induction of osteointegration. Moreover, MFI coating
enhances the osteoinductive characteristics in comparison

with bare titanium.40 Regarding the importance of antimicrobial activity in the tissue engineering framework, the zeoliteA/chitosan hybrid materials also nullify the immunological
infection after operation, on top of their osteoinductive properties previously mentioned (Figure 4).46

Zeolite and Hemodialysis
A signiﬁcant challenge in improving a genuinely portable,
regenerable hemodialysis system is the ammonia elimination
from a recirculating dialysate ﬂow.47 Due to the impurity

Scheme 1 Schematic diagram of zeolite’s biomedical applications.
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removal features of zeolites, they are employed as a ﬁlter
medium throughout hemodialysis instead of conventional
polymer membranes for elimination of uremic toxins using
the adsorption reaction.47–49 Some zeolites including clinoptilolite, type F, and type W possess an excellent potential for
hemodialysis application in ammonia ion–exchange systems.
These systems can be controlled by washing the column with a
2 M sodium chloride solution after each ion-exchange run.
Also, based on the results of atomic absorption spectroscopy of
the column eluent, no detectable Si or Al leaches from the
zeolite.47 Furthermore, a lot of effort have been placed on
improvement of the adsorption efﬁciency of zeolites versus
toxins in various media.50–52 Besides, in patients undergoing
dialysis with chronic renal failure, the ability of zeolite

Derakhshankhah et al

(FAU13× and FERCP914C) to reduce ROS production in
extracorporal circuits was suggested as valuable as antioxidant
supplementation (ie, vitamin E) leading to a lower mortality.53

Zeolite and GI Tract Illnesses
Some natural zeolites had been initially found as effective
antidiarrheal effectors and stepped into the realm of clinical trials complying with the Cuban Drug Quality Agency
standards. Based on the results of several physiochemical,
microbiological, translational, and clinical experiments,
puriﬁed natural clinoptilolite-Enterex has been introduced
as a new antidiarrheal drug. Despite the initial hypothesis,
where the anti-diarrheic effects of zeolites were ascribed to
its bactericidal activity and/or ability to shortening the

Figure 4 (A) Photographs of zeolite-A/chitosan hybrid composites. (B) Photograph exhibiting the transparency (up left) and ﬂexibility (left down) of the zeolite-A/chitosan
hybrid ﬁlm and SEM image of the cross-section of the ﬁlm (right). (C) The internal architecture of the pure chitosan scaffold with diverse magniﬁcations. The internal
microstructure of zeolite-A/chitosan hybrid composites with diverse zeolite percentages of 20 wt.% (D), 35 wt.% (E), 45 wt.% (F) and 55 wt.% (G). (H) The pore size
distribution diagram of the pure chitosan scaffold and zeolite-A/chitosan hybrid composites with diverse zeolite percentages. Reprinted from Yu L, Gong J, Zeng C, et al.
Preparation of zeolite-A/chitosan hybrid composites and their bioactivities and antimicrobial activities. Mater Sci Eng C. 2013;33(7):3652–3660. Copyright 2013, with
permission from Elsevier.46
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intestinal transit ingest similarly to that of the effects
observed in the animal GI tract, no signiﬁcant antibacterial
activity and reduction in intestinal transit ingest was
observed. The authors of the paper proposed a pharmacological mechanism for the efﬁcacy of natural zeolites
against diarrhea mediated by adsorbing of bile acid, aﬂatoxin B1, and glucose.54 Nevertheless, the anti-diarrheic
essence of the natural zeolites (clinoptilolite tuff particles)
was recently reviewed from pharmacodynamic and pharmacokinetic standpoints, where the M-cell intestinal
epithelium cells accommodate the internalization, lumento-apical transportation, and then exposing clinoptilolite
tuff particles to immunological cells residing in the
Peyer’s patch. The Peyer’s patch hosts a multitude of T
cells, macrophages, and IgA secreting B and plasma cells.
These cells are activated once they contact the transported
clinoptilolite tuff particles on the apical surface and consequently elevate their products including IgA and antimicrobe peptides on the luminal mucosa of the intestine.
The IgA and anti-microbial peptides in the mucosa encompass a physical and chemical barrier preventing the gut
microbiota from a direct contact with the intestinal lumen
membrane, and from this point of view, the oral administration of natural safe zeolites can ameliorate the diarrhea’s
symptoms indirectly.55,56 In addition, in a randomized,
double-blind, placebo-controlled, pilot clinical trial including 23 participants, the pharmacological capacity and
activity of the Absorbatox™, as a potentiated clinoptilolite, against NSAID-induced gastric mucosal erosion
severity was assessed. The patients who received 1500
mg of Absorbatox orally three times a day were compared
to the placebo control patients and demonstrated to be
leveraged with more gastroprotection through a suggested
– but unstudied – mechanism, wherein the binding to
hydrogen ions and biologically active amines is the main
deriver of this pharmacological property.57

Zeolite and Contrast in MRI
MRI is recognized as a method that produces an image of the
target tissue in the body by detecting the nuclear-spin reorientations in an applied magnetic ﬁeld.58 Possessing low
contrast is known as a challenge in MRI technique.
Therefore, contrast agents are administered in high doses to
improve the image contrast.59 All nano-sized porous materials have demonstrated the potential to be applied as MRI
contrast agents,2 so a bright future has been pictured for
zeolites to improve the quality of MRI images. Zeolites
encompass high-spin metals capable of binding to water
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molecules giving rise to producing signiﬁcantly faster proton
spin relaxation times.60 Besides, the accumulation of zeolites
at speciﬁc targets is desirable for MRI application, which is
possible either by adding biologically particular portions to
the surface of zeolites by trialkoxysilane condensation process or functionalizing zeolites by molecular targeting vectors, such as aptamers and peptides that possess a highly
speciﬁc binding afﬁnity to cell surface receptors.61
Although gadolinium ions (Gd3+) are considered as suitable MRI contrast agents, they cannot be administered
directly because of their intrinsic toxicity.62 However, Gd3+
loaded zeolites31,63 have been examined as MRI contrast
agents for application in the digestive system. Moreover,
FAU-type zeolite materials appear to be perfect carriers for
Gd3+ ions owing to their ion-exchange capability.61 After
several safety and efﬁcacy evaluations, microparticulate
Gd3+ loaded zeolite NaY has been veriﬁed as an oral contrast
agent.64 Based on clinical Phase II/III multicenter research, it
is concluded that the oral forms of gadolite are considerably
efﬁcient, well tolerated, and safe gastrointestinal contrast
agents that can be used for clinical MRI applications.65 It is
noteworthy that no gadolinium was observed in urine or
blood samples, and no remarkable side effects were mentioned according to clinical trials’ reports.66
Recently, the application of Gd3+ loaded NaY NPs as an
MRI contrast agent has been reported (Figure 5).67 Gd3+
loaded NaY NPs possess a desirably higher relaxivity as
compared to the micrometer-sized zeolite.68 Additionally,
since a more efﬁcient water exchange rate through the pores
leads to higher relaxivity of porous materials, nanozeolites
with large cavities are desired for utilization as MRI contrast
agents.69 In addition to Gd3+ loaded zeolites, Ln3+ loaded
zeolites are also considered as promising MRI contrast agents
that have been studied by Peters and Djanashvili.70

Zeolite and Antitumor Adjuvants
Regarding the regulatory role of zeolites in the immune
system, they hold a promising application as antitumor
adjuvants.71 Recently, the natural clinoptilolite zeolite has
been considered as a useful adjuvant in cancer treatment.72
Tumor size reduction, survival time enhancement, and overall health improvement have been reported during the oral
administration of natural clinoptilolite to mice and dogs
having various types of tumors. Based on in vitro studies,
the ﬁne powder of clinoptilolite provokes the expression of
p21WAF1/CIP1 and p27KIP1 tumor suppressor proteins.
Furthermore, it suppresses the protein kinase B (c-Akt)
and thus blocks cancer cell growth.73 Besides, results of in

International Journal of Nanomedicine 2020:15

International Journal of Nanomedicine downloaded from https://www.dovepress.com/ by 134.48.159.153 on 04-Jan-2022
For personal use only.

Dovepress

vivo studies on TMA-zeolite orally administered to mice
and dogs and in vitro studies of its effect on tissue culture,
accomplished by another research group, endorse the results
obtained for clinoptilolite zeolite.74 In addition, administration of activated TMA-zeolite to cancer and diabetic
patients leads to the reduction of oxidative stress which is
associated with the general-health improvement.75
Furthermore, micronized zeolite clinoptilolite has been
employed as an adjuvant for doxorubicin, a conventional
chemotherapy medicine. This combined orally-administered treatment gently improved the efﬁcacy of doxorubicin as an anticancer drug, and it also decreased the amount
of cancer cells metastasized to the lungs in cancer-bearing
mice and dogs.76

Zeolite and Antibacterial Agents
Compounds offering antibacterial activity eradicate bacteria (bactericides) or impede their growth (bacteriostatic)
without possessing toxicity for the nearby tissues. The
most well-known antibacterial agents are modiﬁed versions of natural compounds. Regarding the evolutionary
concept of emerging inheritable bacterial resistance to
conventionally prescribed organic antibacterial agents,
medical pathologists are trying to ﬁnd new strategies to
overcome the emergence of multi-drug resistant bacteria.
Among them, nanoscale solids, due to their high surface
area to volume ratio and less toxicity, are recognized as
effective antibacterial agents.77–79 Besides, inorganic antibacterial materials not only do offer more thermal and
chemical stability during nanocomposite preparation, but
also possess more ﬂexible structures in alloys, nanocomposites, and coatings.80 Silver (Ag) has been highlighted
among other inorganic metals due to introducing the most
well-established antibacterial properties. To guarantee the
long-term antibacterial activity of Ag NPs, they were
incorporated to zeolite media,79,81–90 as zeolite particles
could hold silver ions and protect their bacteriostatic properties which lie on their ion-exchangeable sites, and this
depends on composition of the selected zeolite, eg, A
zeolite, X zeolite, Y zeolite, etc.30 Based on a research
by Dong et al on the antibacterial properties of Ag-containing nanozeolites, E. coli cells were immediately
destroyed upon exposure to water forms of ultra-small
EMT-type zeolite containing Ag0 or Ag+ ion.88
In addition to silver, the antibacterial property of copper
(Cu) was also enhanced by its introduction to the zeolite
immobilized in a solid matrix. Controlled release of Cu ions
during a period of time and adjustable regulation of Cu ion
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concentration in the system were accounted as advantages
of employing Cu-FAU zeolite. Cu-FAU zeolite has demonstrated antibacterial activity, especially against gram-negative bacteria, eg, Pseudomonas aeruginosa, Acinetobacter
baumanii, and Klebsiella pneumoniae. Furthermore, applying the colloidal forms of Cu-FAU on surfaces of healthcare
settings was suggested as an alternative for antibiotic treatment against ESKAPE pathogens including Acinetobacter
baumanii, Klebsiella pneumoniae, Staphylococcus aurous,
Pseudomonas aeruginosa, Enterococcus species, and
Enterobacter species (Figure 6).91

Zeolite and Dental Application
Dental application of zeolite polymer for orthodontic purposes was achieved by using inorganic agents, such as
zeolite NPs, for continued release of the active ingredient,
eg, silver, into the mouth cavity over a long time. Due to
long-lasting effects of zeolites in the mouth environment,
even in a prolonged contact with saliva, they were recognized as the most effective delivery platform for antimicrobial agents.92 Furthermore, the inclusion of zeolite into
the cement dental composite ingredients was performed,
and as a result, zeolite increased the resistance of the
composite material against acidic environments bred by
inﬂamed dental tissues and also against alkali-aggregate
expansion caused by thermal treatment.93 For root-end
ﬁllings, various substances were utilized including amalgam, resin-modiﬁed glass ionomers, glass ionomer cement
(GIC), and mineral trioxide aggregate (MTA).94–97
The in vitro antibacterial activity of two-experimental
GICs, recommended for endodontic applications,32,98,99
combined with silver zeolite (SZ) at 0.2% and 2% mass
fraction concentrations was reported on Streptococcus
milleri, Staphylococcus aureus, and Enterococcus faecalis
by carrying out the agar diffusion inhibitory test. It was
concluded that adding SZ increased the antibacterial
effects in glass ionomer cement proportionally to its
concentration.100
Besides, adding a small amount of SZ composition into
MTA was reported to possess an inhibitory effect on
Staphylococcus aureus, Escherichia coli, Enterococcus
faecalis, Pseudomonas aeruginosa, etc. The purpose of
the research was to assess whether adding SZ to MTA
would improve the antibacterial effect of MTA, and it was
concluded that SZ had the potential to enhance MTA’s
antibacterial virtue.101

submit your manuscript | www.dovepress.com

DovePress

Powered by TCPDF (www.tcpdf.org)

373

Dovepress

International Journal of Nanomedicine downloaded from https://www.dovepress.com/ by 134.48.159.153 on 04-Jan-2022
For personal use only.

Derakhshankhah et al

Figure 5 (A) The magnetic ﬁeld dependence of longitudinal proton relaxation (NMRD proﬁles) of GdNaY-2.3 recorded at different temperatures. (B) NMRD proﬁles at different
Gd3+ loadings for the GdNaY samples evaluated at 37 ºC. (C) Temperature dependence of the proton relaxivity at 20 MHz: GdNaY-1.3 ( ), GdNaY-2.3 ( ), GdNaY-3.6 ( ), GdNaY5.0 ( ) and GdNaY-5.4 ( ) and La-2.8-GdNaY-3.3 ( ). Reprinted with permission from Platas-Iglesias C, Vander Elst L, Zhou W, et al. Zeolite GdNaY nanoparticles with very high
relaxivity for application as contrast agents in magnetic resonance imaging. Chem Eur J. 2002;8(22):5121–5131. Copyright 2002, John Wiley and Sons.67

374

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

DovePress

International Journal of Nanomedicine 2020:15

Derakhshankhah et al

International Journal of Nanomedicine downloaded from https://www.dovepress.com/ by 134.48.159.153 on 04-Jan-2022
For personal use only.

Dovepress

Figure 6 (A) Spot inoculation of ESKAPE microorganisms following treatment with the Cu-FAU suspension. Every drawn part on the plates above corresponds to 20-min
sampling time (40 mins for E. faecalis); total sampling time 0–140 mins (0–280 mins for E. faecalis). Microorganisms (clockwise): K. pneumoniae, E. cloacae, P. aeruginosa, A.
baumannii, S. aureus and E. faecalis. (B) Summary of the average killing times calculated in the semi-quantitative assays. Reprinted from Redfern J, Goldyn K, Verran J, et al.
Application of Cu-FAU nanozeolites for decontamination of surfaces soiled with the ESKAPE pathogens. Microporous Mesoporous Mater. 2017;253:233–238. Copyright 2017,
with permission from Elsevier.91

Zeolite and Excipient Functionality
Undergoing a signiﬁcant evolution, the traditional basics of
excipients changed from chemically simple and pharmacologically inert vehicles to a vital adjuvant with the aim of
assuring and optimizing the efﬁciency of the modern medicinal material. Previously, the attention of the pharmaceutical
industry and Regulatory Authorities was almost addressed to
control the property of the active components rather than

International Journal of Nanomedicine 2020:15

excipients, but due to the rapid progression of economic,
scientiﬁc, technological, and regulatory factors, a considerable
amount of attention has been focused on physical features of
excipients, as well as their role in drug formulation in order to
release the active component in a controlled manner.102
The functionality of a natural zeolite modiﬁed with cationic surfactants was investigated as a drug formulation excipient. Proﬁles related to in vitro drug release from these
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composites suggested that drug release maintenance was
achievable over 8 hrs. Additionally, given the outcomes of
drug uptake and drug release analysis, it was revealed that the
zeolite compositions were capable of being used as advanced
excipients in drug formulations.103
The extended release of diclofenac sodium (DS) from
three natural zeolites (NZ) with cetylpyridinium chloride
(CPC) composites and also from a physical mixture comprising ZCPC-10 and DS was attained over 8 hrs. The kinetic
analysis veriﬁed that the drug release proﬁles almost ﬁtted the
Korsmeyer-Peppas and Bhaskar release models emphasizing a
combination of drug diffusion and ion exchange as the principal release mechanisms in the dissolution medium.104
Recently, to expand natural zeolites based on pharmaceuticals for oral administration of drugs, a study initiated by the
“Italian Ministry for Education, University and Research” has
proposed to consider the 90 wt.% of Na-clinoptilolite as a drug
excipient. Also, based on the recommended experimental
protocols by European, US, and Japanese Pharmacopoeias
performed for “bentonite” as the most available similar reference for Na-clinoptilolite, bentonite has been evaluated as
comparable to marketed ingestible drugs containing clinoptilolite (Figure 7).105

Zeolite and Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder that
is progressive with an approximate prevalence rate of 5 million new patients per year, and 33 million patients are now

Dovepress

suffering from it. Prevalence of AD correlates with ageing, so
that 0.6–8% of adults between 60 and 85 years old are exposed
to AD. This prevalence rate will turn into a critical challenge
by the increasing number of older adults.106
In 1983, various concentrations of both ﬁne (10 nm)
and coarse (less than 5 microns) silica particles were
delivered into the brains of mice and rats employing different methods of administration. Brain reactions to the
presence of the silica were observed by light and electron
microscopy up to one-year post-injection. The intracerebral injection of silica materials in rat led to a neurotoxic
inﬂammatory response, while it did not cause lesions
similar to those which characterize Alzheimer’s disease.
Hence, it remains opaque whether silica is involved in
neuritic (senile) plaque development or not.107 In 1992,
different model aluminosilicate materials were proposed to
promote the in vitro generation of microglia-derived reactive oxygen metabolites (ROM) implying that the potential
cellular mechanism, by which the proposed analogous
aluminosilicate deposits in the core of senile plaques,
might play an essential role in the aetiopathogenesis of
Alzheimer’s.108 In terms of free radical biology, in vivo
aluminosilicate-induced and phagocyte-mediated oxidative
stress were found to conduct the pathogenic mechanism in
Alzheimer’s disease development.109
On contrary, in parallel studies, the traditional paradigm
changed, so that Memo and Manna claimed to prepare an
activated clinoptilolite zeolite possessing a neuroprotective

Figure 7 SEM observation of clinoptilolite crystals in the bulk rock (A, B). Zeolites of the clinoptilolite series demonstrate a thorough cleavage parallel to the (010) plane.
The particle size might be important to correlate the intensity of intestinal irritation and inﬂammation of the different dimension of the administered clinoptilolite-rich
powder. Reprinted from Cerri G, Farina M, Brundu A, et al. Natural zeolites for pharmaceutical formulations: preparation and evaluation of a clinoptilolite-based material.
Microporous Mesoporous Mater. 2016;2231335 (Supplement C):58–67. Copyright 2016, with permission from Elsevier.105
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effect, speciﬁcally when it comes to its antioxidant activity in
the mitochondria and thus its beneﬁt in neuropathologies, eg,
Alzheimer’s or Parkinson’s disease, where the reactive oxygen species (ROS) play an important role.110
AD is usually distinguished by many symptoms, such
as amyloid-β deposition in amyloid plaques, neuroﬁbrillary tangles, neuronal loss, and cognitive deﬁcits. The
veriﬁed hypothesis for AD pathology is the amyloid-β
deposition in the brain which causes disruption of neuronal
cell membranes, imbalance in neuronal circuit hemostasis,
and eventually the neuron demise.111 Therefore, according
to the amyloid-β hypothesis, targeting these amyloid structures and preventing amyloid formation have come to the
attention of many nanomaterial scientists as a treatment
strategy for AD through this framework.112
By emphasizing the antioxidant effects of the micronized zeolite (MZ) for ageing-related neurodegeneration,
administration of MZ to a transgenic mice model of AD
resulted in no toxicity or adverse effects even in a long-term
period. Unexpectedly, MZ treatment seemed to prevent
amyloidogenic processing of Aβ due to a considerable
decrease in Aβ42 levels in MZ-treated transgenic mice.113
Lately, ﬁbrinogen protein was detected in the brain
of AD patients which could be due to the blood brain
barrier (BBB) impairment occurring as a result of AD.
Fibrinogen, as a soluble plasma glycoprotein, plays
important roles in blood clotting, thrombosis, and
inﬂammation. In regards to the new etiology of AD
development, targeting the Aβ−ﬁbrinogen interaction
has been hypothesized as a practical therapeutic
approach for either prevention or treatment of AD.114,115
Recently, we studied EMT-type zeolite nanocrystals that
could bind to the ﬁbrinogen molecules in contact with the Aβ
proteins. EMT zeolite suppressed the Aβ−ﬁbrinogen interaction with abnormal clots, and the template-free zeolite NPs
demonstrated the advantages of being nontoxic and biocompatible in physiological media. By employing both Aβ (1
−42) and Aβ (25−35) to interact with Aβ−ﬁbrinogen, it was
also determined that the effect of zeolite NPs did not rely on
Aβ sequences. The computational and experimental results
were both in accordance with each other revealing the signiﬁcant residues and interactome effectors contributing to the
interaction of Aβ with ﬁbrinogen (Figure 8).116
Zeolite nanomaterials have been applied not only in the
treatment of AD but also in developing diagnostic instruments
and biosensors for AD. Following the merits and shortcomings
of zeolite-based solid-phase extraction from the crude extract
of Corydalis yanhusuo, 14 acetylcholinesterase (ACE)
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inhibitors were screened, among which 10 (ACE) inhibitors
were newly discovered.117

Zeolite’s Protein Corona Composition
and Biological Interactions
Nanomaterials have been employed in multiple targeting, diagnostics, and therapeutic applications depending on their size.
Once a nanomaterial is introduced to a physiological medium,
eg, blood, it is rapidly covered by a layer of proteins (ie, protein
corona) giving it a new biological identity. Efforts to determine
the rules that govern the corona composition and its consequent
biological identity could change their fate.118–120 Most of the
rules determining the interaction of proteins with biomaterials
could be applied to interactions of proteins with nanomaterials.
However, it should be noted that due to highly curved surface
of nanomaterials relative to proteins and also widely distribution of nanomaterials throughout the body, they may act differently in diverse media according to their physicochemical
features.121 The biological identity of corona protein could
vary depending on distinctive protein types belonging to
diverse individual physiological compartments and their concentrations along with the nanomaterial’s characteristics
including shape, size, and surface chemistry. The biological
identity of a nanomaterial undergoes evolving after being
exposed to a new physiological medium, eg, after migration
of the nanomaterial from blood to other physiological compartments, such as the cytoplasm.120,122–124
Protein corona of two types of ultra-small zeolites, with
LTL- and EMT-type structures, after exposure to 10% and
100% human plasma was analyzed via the nLC-MS/MSPEAKS analysis, so that 99 and 66 kinds of proteins in
LTL-corona and EMT-corona were veriﬁed, respectively.
Among them, EMT-corona incubated with 100% human
plasma displayed a very high afﬁnity for ﬁbrinogen and a
very low afﬁnity for albumin.38
Zeolites that have been utilized for numerous years by US
forces in Iraq and Afghanistan to induce coagulation and to
stabilize life-threatening injuries, in the form of Ca-zeolite,
have demonstrated to be dressed by protein corona, abundantly
with thrombin. Their discovery emphasized the connection of
the biomolecules in the protein corona with the procoagulant
activity of the zeolite particles picturing a bright future for the
hemostatic mechanisms of zeolite nanomaterials.125
Also, the NP-induced inﬂammatory cytokines were
shown to rely on the different protein concentrations during incubation of three NPs including hydrophobic sulfonated-modiﬁed polystyrene NPs, hydrophilic amorphous
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Figure 8 Total time determined for clot formation and breakdown in the presence of Aβ 1–42 and corona coated EMT zeolite NPs achieved from (A and B) 10% and (C
and D) 100% plasmas. * P< 0.1. Reprinted with permission from Derakhshankhah H, Hajipour MJ, Barzegari E, et al. Zeolite nanoparticles inhibit Aβ–ﬁbrinogen interaction
and formation of a consequent abnormal structural clot. ACS Appl Mater Interfaces. 2016;8(45):30768–30779. Copyright © 2016, American Chemical Society.116

SiO2, and hydrophilic crystalline EMT zeolite with human
plasma. Nevertheless, among them, the EMT zeolite
remarkably exhibited no toxicity independent of the
plasma protein concentrations.126
To open the possibility of applying zeolite’s protein
corona for therapeutic purposes, their protein corona compositions after exposure to 10% and 100% plasma were
explored. The protein corona composition is dominantly
related to protein concentration and chemical identity of
zeolites but less signiﬁcantly to NPs concentration. Protein
corona compositions were identiﬁed through semi-quantitative assessment of the amount of proteins. Regarding the
fact that albumin and immunoglobulin G (IgG) 38–40 are
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the most abundant proteins in plasma, the composition of
EMT- and FAU-corona, exposed to 10% plasma, was
merely consisted of albumin and IgG. More strikingly, the
number of existing proteins in the corona of zeolite NPs
exposed to 100% plasma was less than that of the NPs
exposed to 10% plasma which could be explained by the
competition theory, ie, proteins compete to occupy the surface of the NPs. It was also concluded that since EMTzeolite are more hydrophilic than FAU-zeolites, proteins are
adsorbed more on EMT-zeolite’s surface. Regarding zeolite
NPs capability to quicken the time of blood clot formation,
they may be offered for the use of hemophilic patients (ie,
hemophilia A (F-VIII deﬁcient) and hemophilia B (F-IX
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deﬁcient)) with a risk of bleeding. Besides, since APOC-III
would be selectively captured, it could minimize the activation of lipoprotein lipase inhibition while undergoing hypertriglyceridemia treatment (Figure 9).127
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Zeolites and Drug Delivery
Initially, inorganic materials had shown not enough biocompatibility to be employed in drug delivery systems.
However, recently, the results of successful experiments
on nano-scale zeolites with a larger external surface area,
up to an order of magnitude as compared to micron-sized
zeolites, indicate their applicability for a wide spectrum of
applications in drug delivery systems.128–131
Additionally, the interaction of both puriﬁed and modiﬁed natural clinoptilolites with metronidazole and sulfamethoxazole demonstrated that the organic molecules did
not exhibit degradation after contacting with different zeolite products at any pH levels indicating their promising
advantage for drug delivery applications.132
The application of various NPs containing zeolite in drug
delivery systems have been categorized in Table 1 in a
chronological order. Only two-early studies131,133 focus on
oral administration of two types of zeolite NPs to assess their
capacity for sustained release and enhanced delivery of
cyclophosphamide and fenbendazole, respectively. The
other studies demonstrate the efﬁciency of various zeolite
NPs to deliver different drugs in vitro. It is noticeable that due
to the unique properties of zeolite-L nanocrystals, intracellular delivery of DAPI probes paved the way for future drug
delivery systems targeting intercellular macro molecules
(Figure 10).134 The chemotherapeutic doxorubicin is the
most abundantly loaded drug into the zeolite NPs. Due to
obvious advantages of zeolites, eg, enhancing bioavailability
of drugs even in gastrointestinal route, their application in
oral delivery of drugs that target gastric cancer and intestinal
worms is a possibility in a foreseeable future.

Conclusion
Zeolites are crystalline porous materials known for a decade and have recently become very attractive for researchers due to their biomedical applications, especially when it
comes to safety and non-toxicity of some natural zeolites
whose oral administration was found to safely and effectively exert gastro-beneﬁcial effects for the patients suffering from diarrhea and other diseases. Signiﬁcant
prominence of nanozeolites as compared to other nanostructured porous material lies in their low cytotoxicity,
high payload capacity, and efﬁcient delivery. According
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to the importance of zeolite nanocrystals’ characteristics,
most of the research focus on engineering the framework
composition, size, morphology, and secondary porosity of
these NPs. In the relevant approaches for fabrication of
zeolite NPs, there is still a serious challenge regarding the
heterogeneity of the NPs, and controlling the zeolite
nucleation process plays a key role in achieving the product homogeneity. For example, for FAU- and EMT-type
zeolites, it has been shown that the optimal condition
results in great achievements in costly production of particles with a uniform size distribution. Nonetheless, controlling zeolite nucleation and growth in such systems is
difﬁcult and needs to be further investigated.
Complexity of the fabrication of zeolite NPs and, more
importantly, the intricacies regarding corona-protein biological identity of zeolite NPs yet remain poorly understood. The latter is of great signiﬁcance in the context of
predicting the pharmacodynamics and pharmacokinetics of
the corona-covered zeolite NPs whose physiological activities are dictated by their biomolecular corona composition. Due to the fact that some NPs are intrinsically able or
chemically modiﬁed to cross a physiological barrier, such
as the BBB, different corona proteins with different patterns of composition could mask the NPs and consequently
confer them a different biological identity. The biological
identity of the zeolite-protein corona directly depends on
the type and amount of individual proteins residing on the
corona layer and indirectly on other corona-interacting
proteins, such as receptor proteins on the cell membranes
whose occupation and activation by zeolite corona proteins manifest different signaling and cellular toxicity
readouts. Thereby, given the fast accumulative breakthroughs in the bioanalytical ﬁeld, in particular within
proteomics, the future of zeolite NPs translational research
is dependent on the advancement of the tools applied for
probing and exploring the diseases-speciﬁc zeolite corona
proteins. For example, for deep understanding of the zeolite NPs metabolism and physiological fate, researchers
may take advantage of the corona-dependent biological
identity and manipulate its composition, so that it allows
the receptors on the cell membrane to internalize the
zeolite NPs readily. In addition, the intracellular incidents
following internalization can be tracked and probed.
Thereby, it seems feasible to integrate a probe protein to
the corona composition in order to accurately spot zeolite
NPs’ localization inside the cells.
In this review, our focus was speciﬁcally on the application of zeolite NPs and their expanding outreach in biology
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Figure 9 nLC-MS/MS test of corona-associated proteins on EMT-zeolite (A) and FAU-zeolite (B) NPs. Apolipoprotein C-III (APOC-III), ﬁbrinogen alpha chain (FIBA), ﬁbrinogen
beta chain (FIBB), ﬁbrinogen gamma chain (FIBG), albumin (ALBU), IGHG1, IGHG2 and IGHG4. Reprinted from Rahimi M, Ng E-P, Bakhtiari K, et al. Zeolite nanoparticles for
selective sorption of plasma proteins. Sci Rep. 2015;5:17259. Copyright © 2015, Springer Nature.127

and medicine. We know that the cytotoxicity and bio-applicability assessments of each molecule are a decisive topic
prior to its use in clinical practices. Hence, although cytotoxicity studies on zeolite NPs are less than other mesoporous
NPs, most of the papers report low cytotoxicity of these
frameworks. As presented, we aimed to provide an overview
of the widespread biomedical applications of zeolite NPs as
antidiarrheal agents, antitumor adjuvants, antibacterial
agents, and MRI contrast agents along with their utilization
in studies on bone formation, Alzheimer’s disease development, excipient functionality, protein corona composition,
biological interactions, and their hemodialytic, drug delivery,
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and dental applications. We hope the researchers ﬁnd the
content of this review helpful for their future works.

Highlights
● Signiﬁcant prominence of nanozeolites as compared to

another nanostructured porous materials are their low
cytotoxicity, high payload capacity, and efﬁcient delivery.
● The control of the zeolite nucleation process plays a
key role in achieving homogeneous nanoparticles.
● The size and uniformity of zeolite nanoparticles with
improved biocompatibility lead to great achievements
in biomolecular delivery capacity.
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Figure 10 Optical microscopy images demonstrating U251 cells treated with (A) 0 mg/mL of drug delivery system (DDS), (B) 0.05 mg/mL of temozolomide (TMZ)
containing mordenite zeolites (MOR) (TMZ0.026-MOR) and (C) 0.75 mg/mL of TMZ0.026-MOR under 100x magniﬁcation and found that above 0.75 mg mL1 there is high
rate of cell dead, probably because from this concentration the cells are completely coated by the zeolite, which compromise the cell-nutrient exchange with the culture
media. Reprinted with permission from Ref [134] Copyright (2011), ROYAL SOCIETY OF CHEMISTRY.

● The application of zeolite nanoparticles and their

expanding outreach in biology and medicine.
nanoparticles as promising antidiarrheal
agents, antitumor adjuvants, antibacterial agents, drug
carriers, and MRI contrast agents due to their favorable
cytotoxicity, excipient functionality, protein corona
composition, and biological interactions.

● Zeolites
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